On Wednesday, October 28, 2020, V-BID Center director, A. Mark Fendrick, presented at the Community Oncology Alliance Payer Exchange Summit on Oncology Payment Reform, which brought stakeholders together to talk about what is and what is not working to achieve overall better cancer care with lower costs.
V-BID Center director, A. Mark Fendrick, presented at the Coalition Against Surprise Medical Billing Hill Briefing. During this event, leading voices in health policy discuss the importance of closing the loopholes that allow out-of-network providers and private equity-backed specialists to ‘balance bill’ patients during in-network care.
V-BID Center director, A. Mark Fendrick, presented at the Coalition Against Surprise Medical Billing Hill Briefing. During this event, leading voices in health policy discuss the importance of closing the loopholes that allow out-of-network providers and private equity-backed specialists to ‘balance bill’ patients during in-network care.
V-BID Center director, A. Mark Fendrick, presented to the 2nd Sichuan Health Insurance Forum, hosted by the Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital (SAMSPH).
On Tuesday, August 18, 2020, the V-BID Center director, A. Mark Fendrick, presented virtually at the National Association of Health Data Organization (NAHDO) 35th Annual Conference: Building a Bridge Between Data and Policy.
National Clinician Scholars Program Enhancing Access & Affordability to Essential Clinical Services On Wednesday, July 15th, 2020, Dr. A. Mark Fendrick, MD, Director of the Center for Value-Based Insurance Design (V-BID), gave a lecture to the University of Michigan IHPI National Clinician Scholars Program in Ann Arbor, MI. His presentation, entitled, "Enhancing Access & Affordability to Essential Clinical Services", is available below. Dr. Fendrick's Presentation
Precision Patient Assistance Programs to Enhance Access to Clinically Indicated Therapies: Right Drug, Right Time, Right Cost-Share Cost-Sharing and its Consequences Consumer cost-sharing for medical care and medications is high and getting higher. The average deductible for employer-sponsored single coverage increased by more than 250% between 2006 and 2016, and is now nearly $1,500.1 Even after any applicable deductible has been satisfied, patients are often liable for high copayments and coinsurance. The average copay or coinsurance for a fourth-tier drug in employer-sponsored coverage was $102 in 2016. In 2016, more than 25% of Medicare beneficiaries spent 20% or more of their income on out-of-pocket health care costs,2 with a significant share of this spending devoted to coinsurance of 25-33% for specialty medications. Most Medicare Part D beneficiaries taking a single specialty drug will pay no less than $2,000 over the course of one year[a].3 For Medicare Part [...]
On April 10, 2020 at 12PM EDT, the V-BID Center's A. Mark Fendrick will virtually present at the University of Michigan Department of Internal Medicine Grand Rounds.
Breaking News: On March 11, 2020 IRS issued guidance (Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19) confirming that health plans and employers may reduce or eliminate cost-sharing for COVID-19 screening, treatment, and vaccination, including for Americans enrolled in high-deductible health plans coupled with Health Savings Accounts.
On March 25, 2020, leaders from across the country and the health care spectrum came together to discuss strategies for tackling some of the industry’s most relevant challenges at our virtual 15th anniversary Summit.
On March 12, 2020, the V-BID Center's A. Mark Fendrick presented at the Institute of Continuing Legal Education (ICLE) in Plymouth, MI.
On February 20, 2020, the V-BID Center's A. Mark Fendrick presented the V-BID model to the Health Resources and Services Administration's Advisory Committee on Interdisciplinary, Community-Based Linkages.
On February 13, 2020, the V-BID Center's A. Mark Fendrick presented at The National Academy of Medicine's Value Incentives & Systems Action Collaborative. His session identifies V-BID X as the template to guide organizations interested in incorporating cost-neutral, value-based principles into their plan benefit design.
This week, the cost-saving principles of V-BID have made headlines. Fortune Magazine highlights how the V-BID Center‘s successes in policy enable high-deductible insurance plans to cover the cost of essential services. Reuters News reports on how CVS is putting V-BID principles into practice with the launch of a new program.
On Thursday, January 30th, Dr. A. Mark Fendrick, MD and the V-BID Center hosted the webinar 'VBID X: A New Plan Option for the Individual Health Insurance Market' for the Northeast Business Group on Health. V-BID X is geared towards employers and serves a template to guide incorporation of the VBID model - cost-neutral, value-based principles - into the organization's plan benefit design.
